Wakefit Innovations listed flat on Monday, debuting at Rs 195 on the NSE and slightly lower on the BSE, in line with muted grey market expectations. The Rs 1,289-crore IPO saw moderate demand, with investors cautious amid aggressive valuations and a limited profitability track record despite strong brand presence.Read More

Corona Remedies Share Price: Corona Remedies debuted on Dalal Street with a significant 38.42% premium, opening at Rs 1,470 on NSE and Rs 1,452 on BSE. The Rs 655 crore IPO, entirely an offer for sale, was oversubscribed 144.5 times, highlighting strong investor confidence in its business model and niche market leadership.Read More

Indian equity markets could see earnings surprises over the next one to two years as Nifty valuations hover near long-term averages, says Complete Circle Capital’s Aditya Kondawar. Banking, manufacturing and autos may lead gains, while small and midcaps could recover as trade deals progress and credit growth accelerates India’s push toward a $8 trillion economy.Read More

Defence stocks face continued selling pressure, with technical indicators suggesting further weakness. Geojit Investments’ Anand James advises caution against premature bottom-fishing in the sector. Meanwhile, the Nifty Metal index shows bullish signs with strong upside potential, and specific stock recommendations are provided for Anantraj and Sequent.Read More

In the Nifty200 segment, four stocks witnessed a 5-year swing high at the close on December 12, suggesting bullishness in counters, according to stockedge.com’s technical scan data.Read More

ETFs are low-cost, exchange-traded investment funds that offer real-time pricing, diversification and transparency, making them a popular choice for Indian, US and global investors seeking efficient, long-term wealth creation.Read More

Vodafone Idea shares: The government is likely to extend a 4–5 year interest-free moratorium on over Rs 83,000 crore of AGR dues, easing financial stress and improving near-term liquidity.Read More

ICICI Prudential AMC’s IPO saw a surge in grey market premium to 14% on Day 2, reflecting strong investor optimism. The Rs 10,602-crore issue, a 100% offer for sale, was 72% subscribed on Day 1. Brokerages are largely positive, citing the AMC’s market leadership and profitability, though valuations are considered rich.Read More

Nilesh Shah of Kotak Mahindra AMC advocates a pragmatic 2026 investment strategy, emphasizing earnings visibility and valuation comfort. He suggests a multi-asset allocation of 55% equities (midcap, largecap, smallcap), 20% precious metals (favoring gold), and 30% fixed income, balancing risk and return amid market shifts.Read More

Cholamandalam anticipates margin gains in the second half of FY26, driven by lower funding costs and RBI rate adjustments. The company maintains its asset under management growth forecast. Demand for consumer loans is rising, supported by GST reductions. Commercial vehicle segment weakness is seen as seasonal. Asset quality is expected to improve.Read More